An exciting new scientific technology has made it possible to tinker with the very DNA that makes us who we are, offering up fresh hope of new cures for difficult diseases.
Merck CEO Kenneth Frazier, who has led the company for a successful run of nearly a decade, recently said he was looking forward to the next chapter.